Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 25 milligram and valsartan 320 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
3 |
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 25 milligram and valsartan 320 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Sulfacetamide sodium 150 mg/mL eye solution |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely aspirin 325 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Naphazoline hydrochloride 1 mg/mL eye solution |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Duloxetine (as duloxetine hydrochloride) 20 mg gastro-resistant oral capsule |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
3 |
Product containing precisely magnesium hydroxide 700 milligram and omeprazole 40 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Product containing precisely magnesium hydroxide 700 milligram and omeprazole 40 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
3 |
Product containing precisely magnesium hydroxide 700 milligram and omeprazole 40 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Clotrimazole 10 mg/mL vaginal cream |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely lansoprazole 30 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Tobramycin 3 mg/mL eye solution |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Phenylephrine hydrochloride 100 mg/mL eye solution |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Nicotinic acid 750 mg and simvastatin 20 mg prolonged-release oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Nicotinic acid 750 mg and simvastatin 20 mg prolonged-release oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Trazodone hydrochloride 150 mg prolonged-release oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Phenytoin sodium 200 mg prolonged-release oral capsule |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely hydroxyamfetamine hydrobromide 10 milligram/1 milliliter and tropicamide 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely hydroxyamfetamine hydrobromide 10 milligram/1 milliliter and tropicamide 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Product containing precisely risperidone 3 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely valproic acid 250 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely bepotastine besilate 15 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely erythromycin 333 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye suspension (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
pramipexoldihydroklorid 3 milligram, depåtablett |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
Clindamycin phosphate 20 mg/mL vaginal cream |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Prednisolone acetate 2 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Has concentration strength denominator unit |
False |
mg |
Inferred relationship |
Some |
2 |
Prednisolone acetate 2 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Has concentration strength denominator unit |
False |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely bacitracin 500 unit/1 gram conventional release eye ointment (clinical drug) |
Has concentration strength denominator unit |
False |
mg |
Inferred relationship |
Some |
1 |
Diphenhydramine hydrochloride 12.5 mg chewable tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Mirtazapine 15 mg orodispersible tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
3 |
Cetirizine hydrochloride 5 mg chewable tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 1 mg oral capsule |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
gentamicinsulfat 3 milligram/milliliter, lösning för oftalmiskt bruk |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely trimethadione 150 milligram/1 each conventional release chewable tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely fluorometholone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Olanzapine 5 mg orodispersible tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely aspirin 75 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely nicotinic acid 500 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Product containing precisely nicotinic acid 500 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Desloratadine 2.5 mg orodispersible tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
3 |
Product containing precisely mirtazapine 30 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
3 |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely sodium salicylate 650 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Cetirizine hydrochloride 10 mg chewable tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Doxycycline (as doxycycline hyclate) 150 mg gastro-resistant oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely famotidine 10 milligram/1 each conventional release chewable tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely bupropion hydrobromide 522 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely pilocarpine hydrochloride 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
3 |
Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
3 |
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Product containing precisely fluorometholone 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely olanzapine 10 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Product containing precisely memantine hydrochloride 21 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Nicotinic acid 250 mg prolonged-release oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Loteprednol etabonate 5 mg/mL eye suspension |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Erythromycin ethyl succinate 200 mg chewable tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely axitinib 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
diklofenaknatrium 1 milligram/milliliter, lösning för oftalmiskt bruk |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
Topiramate 50 mg oral capsule |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
pramipexoldihydroklorid 1,5 milligram, depåtablett |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
pramipexoldihydroklorid 4,5 milligram, depåtablett |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
Alcaftadine 2.5 mg/mL eye solution |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Risperidone 4 mg orodispersible tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
nepafenak 1 milligram/milliliter, suspension för oftalmiskt bruk |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/g eye ointment |
Has concentration strength denominator unit |
False |
mg |
Inferred relationship |
Some |
1 |
cyklobensaprin (som cyklobensaprinhydroklorid) 15 milligram, depåkapsel |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
Tobramycin 3 mg/g eye ointment |
Has concentration strength denominator unit |
False |
mg |
Inferred relationship |
Some |
1 |
cyklobensaprin (som cyklobensaprinhydroklorid) 30 milligram, depåkapsel |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
Hydrocortisone 10 mg/mL eye solution |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Memantine hydrochloride 28 mg prolonged-release oral capsule |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely zinc sulfate 220 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Aspirin 81 mg gastro-resistant oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Unoprostone isopropyl 1.5 mg/mL eye solution |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Propamidine isetionate 1.5 mg/g eye ointment |
Has concentration strength denominator unit |
False |
mg |
Inferred relationship |
Some |
1 |